XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 6 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include JBB, UOUA, FCUTEL, NHICDNS, and EPOLATERY. The owner is based in XIAMEN.

UNIT 1812, NO. 4672, XIANYUE ROAD, HULI

DISTRICT

XIAMEN 361000 , CN

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EPOLATERY
EPOLATERY
Registered 2020
JBB
JBB
Registered 2020
UOUA
UOUA
Registered 2020
NHICDNS
NHICDNS
Registered 2019
FCUTEL
FCUTEL
Registered 2019

Trademark Classifications

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (6 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. have?

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. file in?

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are XIAMEN CHENWEIXI TECHNOLOGY CO., LTD.'s most well-known trademarks?

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as JBB, UOUA, FCUTEL, NHICDNS, and EPOLATERY. These are among 6 currently registered trademarks in the portfolio.

What is XIAMEN CHENWEIXI TECHNOLOGY CO., LTD.'s trademark registration success rate?

XIAMEN CHENWEIXI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.